blood disorder nos; urine abnormal nos; cramps; vaccination site pain; this is a spontaneous report received from a contactable reporter(s) (physician) from the regulatory authority-web. regulatory number: gr-greof-20217536 (ra). a 67 year-old female patient received bnt162b2 (comirnaty), administration date 08may2021 (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. the patient's relevant medical history and concomitant medications were not reported. the following information was reported: blood disorder (medically significant), outcome "unknown", described as "blood disorder nos"; urine analysis abnormal (medically significant), outcome "unknown", described as "urine abnormal nos"; muscle spasms (medically significant), outcome "unknown", described as "cramps"; vaccination site pain (non-serious), outcome "recovered", described as "vaccination site pain". the patient underwent the following laboratory tests and procedures: blood test: unknown results, notes: different values from the previous times (at the same month with the month she got the vaccine, on may 2021); urine analysis: unknown results, notes: different values from the previous times (at the same month with the month she got the vaccine, on may 2021). therapeutic measures were taken as a result of vaccination site pain (with 20 pills of norgesic after a physician's advice). no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

test name: blood analysis; result unstructured data: test result:unknown results; comments: different values from the previous times (at the same month with the month she got the vaccine, on may 2021); test name: urine analysis; result unstructured data: test result:unknown results; comments: different values from the previous times (at the same month with the month she got the vaccine, on may 2021)

na

na